CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
78,364,237
Share change
+6,942,782
Total reported value
$222,589,523
Put/Call ratio
124%
Price per share
$2.84
Number of holders
129
Value change
+$19,711,344
Number of buys
59
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q4 2017

As of 31 Dec 2017, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 129 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 78,364,237 shares. The largest 10 holders included COLUMBIA WANGER ASSET MANAGEMENT LLC, BlackRock Inc., Vanguard Group Inc, FMR LLC, KLP Enterprises, LLC, Meditor Group Ltd, DIMENSIONAL FUND ADVISORS LP, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 129 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.